49LOW

HLS

HEALIUS FPO [HLS]
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.5720 -0.5%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical50
Catalyst61
Sentiment50
Fundamental91
Momentum37
Risk Gate32
Get alerts when HLS's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track HLS — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is picking up steam
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.3x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (1% of range)
  • New substantial holder(s) (1)
  • Elevated short interest (6.3%)
  • CANSLIM I: Institutional ownership (100%)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score distress zone (1.36 < 1.81, low-confidence approx)
  • Days to cover very high (13.3)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-12%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 22% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.55%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about HLS
"What's driving HLS's score?" "How does HLS compare to peers?" "Key risks for HLS?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change in substantial holding
NONE Change of Director's Interest Notice - Kathy Ostin
NONE Change of Director's Interest Notice - Steven Rubic
HIGH Becoming a substantial holder from MQG
Announcement tone +3pts

Recent ASX Announcements

2026-03-24 Change in substantial holding
2026-03-13 Change of Director's Interest Notice - Kathy Ostin
2026-03-12 Change of Director's Interest Notice - Steven Rubic
2026-03-10 Change of Director's Interest Notice - Kathy Ostin
2026-03-09 Becoming a substantial holder from MQG

Key Metrics

$415.3M
Market Cap
3.5M
Avg Volume
1.4x
Vol Ratio
$0.56 — $1.64
52-Week Range
6.3%
Short Interest
N/A
Cash Runway
-69.3%
ROE
-12.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 79%
LLeader vs LaggardlaggardRS: -8
IInstitutional SponsorshippassInst: 100%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #39 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:HLS vs ATXHLS vs PNVHLS vs IMM
Scout Pro — Deeper Analysis for HLS
Try Pro free for 30 days
Share this analysis

Track HLS and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required